|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Product sales, net | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Depreciation and amortization expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest (expense) income, net | |||||
| Gain on sale of net operating losses | |||||
| Loss before provision for income taxes | |||||
| Net loss attributable to noncontrolling interests | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per share applicable to common stockholders - basic | |||||
| Net loss per share applicable to common stockholders - diluted | |||||
| Weighted average shares outstanding and to be issued - basic | |||||
| Weighted average shares outstanding and to be issued - diluted | |||||
Loading...